Immune histories and natural infection protection during the omicron era
Open Access
- 1 July 2025
- journal article
- research article
- Published by Springer Nature in Communications Medicine
- Vol. 5 (1) , 1-10
Abstract
Background: Past immunological events can either enhance or compromise an individual’s future immune protection. This study investigated how different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) natural infection histories before an omicron infection, with or without vaccination, influence protection against subsequent omicron reinfection. Methods: Three national, matched, retrospective cohort studies were conducted in Qatar from February 28, 2020, to August 12, 2024 to compare incidence of omicron reinfection between individuals with two omicron infections (omicron double-infection cohort) and those with one (omicron single-infection cohort); the omicron double-infection cohort with individuals who had a pre-omicron infection followed by an omicron reinfection (pre-omicron-omicron double-infection cohort); and the pre-omicron-omicron double-infection cohort with the omicron single-infection cohort. Results: Here we show that, in the first study, comparing the omicron double-infection cohort to the omicron single-infection cohort, the adjusted hazard ratio (aHR) is 1.27 (95% CI: 1.13–1.43); 0.93 (95% CI: 0.68–1.28) for the unvaccinated and 1.34 (95% CI: 1.18–1.52) for the vaccinated. In the second study, comparing the omicron double-infection cohort to the pre-omicron-omicron double-infection cohort, the aHR is 1.37 (95% CI: 1.13–1.65); 1.12 (95% CI: 0.63–1.97) for the unvaccinated and 1.42 (95% CI: 1.16–1.74) for the vaccinated. In the third study, comparing the pre-omicron-omicron double-infection cohort to the omicron single-infection cohort, the aHR is 0.97 (95% CI: 0.92–1.03); 0.75 (95% CI: 0.66–0.85) for the unvaccinated and 1.03 (95% CI: 0.97–1.09) for the vaccinated. Conclusions: Immune history shapes protection against omicron reinfection, with pre-omicron-omicron immunity enhancing protection, while repeated similar exposures reduce protection against new variants.Keywords
This publication has 59 references indexed in Scilit:
- Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort studyInternational Journal of Infectious Diseases, 2023
- COVID-19 Disease Severity in Persons Infected With Omicron BA.1 and BA.2 Sublineages and Association With Vaccination StatusJAMA Internal Medicine, 2022
- SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunityEnvironmental Research, 2022
- Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccinationCell, 2022
- Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in QatarJAMA, 2021
- Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in QatarInternational Journal of Infectious Diseases, 2021
- Immune imprinting and SARS-CoV-2 vaccine designTrends in Immunology, 2021
- SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individualsiScience, 2021
- COVID-19 (SARS-CoV-2) outbreak monitoring using wastewater-based epidemiology in QatarScience of The Total Environment, 2021
- Ignoring the matching variables in cohort studies – when is it valid and why?Statistics in Medicine, 2013